Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Imai

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of Leukocyte Biology|June 21, 2008
Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytesKenichi Nonaka, Masanao Saio, Tatsuhiko Suwa, et al.
Molecular and Clinical Oncology|August 30, 2018
Local recurrence of T1a rectal cancer following radical endoscopic mucosal resection: A case reportKeita Matsumoto, Nobuhisa Matsuhashi, Takao Takahashi, et al.
In Vivo (Athens, Greece)|January 6, 2021
MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal CancerTakazumi Kato, Nobuhisa Matsuhashi, Hiroyuki Tomita, et al.
Oncology Reports|March 2, 2021
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell linesTomonari Suetsugu, Ryutaro Mori, Manabu Futamura, et al.
International Journal of Oncology|March 3, 2007
TNF expressed by tumor-associated macrophages, but not microglia, can eliminate gliomaJiro Nakagawa, Masanao Saio, Noriyuki Tamakawa, et al.
International Cancer Conference Journal|September 27, 2021
Successful treatment of cervical and upper thoracic esophageal adenocarcinoma using induction chemotherapy followed by surgery: a case reportTakeharu Imai, Yoshihiro Tanaka, Hidenori Ojio, et al.
Medical Oncology (Northwood, London, England)|June 5, 2019
High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapyYunami Yamada, Hironori Fujii, Koichi Ohata, et al.
Indian Journal of Surgical Oncology|September 6, 2021
The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective AnalysisTakeharu Imai, Yoshihiro Tanaka, Yuta Sato, et al.
Molecular and Clinical Oncology|February 7, 2022
Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapyNobuhisa Matsuhashi, Hiroyuki Tomita, Hidenori Tanaka, et al.
Molecular and Clinical Oncology|September 3, 2019
Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancerNobuhisa Matsuhashi, Takao Takahashi, Hironori Fujii, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Leukocyte Biology|June 21, 2008
Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytesKenichi Nonaka, Masanao Saio, Tatsuhiko Suwa, et al.
Molecular and Clinical Oncology|August 30, 2018
Local recurrence of T1a rectal cancer following radical endoscopic mucosal resection: A case reportKeita Matsumoto, Nobuhisa Matsuhashi, Takao Takahashi, et al.
In Vivo (Athens, Greece)|January 6, 2021
MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal CancerTakazumi Kato, Nobuhisa Matsuhashi, Hiroyuki Tomita, et al.
Oncology Reports|March 2, 2021
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell linesTomonari Suetsugu, Ryutaro Mori, Manabu Futamura, et al.
International Journal of Oncology|March 3, 2007
TNF expressed by tumor-associated macrophages, but not microglia, can eliminate gliomaJiro Nakagawa, Masanao Saio, Noriyuki Tamakawa, et al.
International Cancer Conference Journal|September 27, 2021
Successful treatment of cervical and upper thoracic esophageal adenocarcinoma using induction chemotherapy followed by surgery: a case reportTakeharu Imai, Yoshihiro Tanaka, Hidenori Ojio, et al.
Medical Oncology (Northwood, London, England)|June 5, 2019
High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapyYunami Yamada, Hironori Fujii, Koichi Ohata, et al.
Indian Journal of Surgical Oncology|September 6, 2021
The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective AnalysisTakeharu Imai, Yoshihiro Tanaka, Yuta Sato, et al.
Molecular and Clinical Oncology|February 7, 2022
Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapyNobuhisa Matsuhashi, Hiroyuki Tomita, Hidenori Tanaka, et al.
Molecular and Clinical Oncology|September 3, 2019
Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancerNobuhisa Matsuhashi, Takao Takahashi, Hironori Fujii, et al.
Pageof 8